research Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
In this review, researchers found that TNF-α, IL-17, and JAK inhibitors show the most promise for stabilizing and resolving scarring alopecias, with IL-23 and Interferon Alpha Receptor 1 inhibitors also providing some benefits in managing these hair loss conditions.



